Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2019

Mar 27, 2019

34491_dirs_2019-03-27_fb5be04b-30d3-41ff-8a71-4924a993fb96.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A Preferred Stock $ Common Stock (3279170) Indirect
Series B Preferred Stock $ Common Stock (409078) Indirect

Footnotes

F1: The Series A Preferred Stock and Series B Preferred Stock are convertible on a 1-for-2.134686 basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration, and have no expiration date.